Unlocking Autism's Mysteries: Workshop Delves into Mitochondrial Dysfunction

The Simons Foundation Autism Research Initiative (SFARI) recently convened a virtual workshop to explore the burgeoning evidence linking mitochondrial dysfunction to autism spectrum disorder (ASD). This gathering of leading scientists aimed to consolidate current knowledge and identify future research directions in this critical area.

Key Takeaways

• Mitochondrial dysfunction is an emerging risk factor for ASD, potentially explaining a significant portion of cases.
• Developing new tools for analyzing mitochondrial DNA (mtDNA) is crucial for advancing research.
• A subset of ASD risk genes directly or indirectly impacts mitochondrial function.
• Mitochondria play a role in regulating the timing of species-specific neuronal development.
• Environmental factors may interact with genetic predispositions to exacerbate mitochondrial dysfunction in ASD.

Mitochondrial Genome Analysis in ASD

Mitochondria, the powerhouses of cells, generate energy essential for brain function. Emerging research suggests that disruptions in these organelles may contribute to ASD susceptibility. The workshop highlighted the importance of mitochondrial DNA (mtDNA), which mutates at a higher rate than nuclear DNA. Scientists are developing new methods to detect mtDNA heteroplasmy, a phenomenon where typical and mutated mtDNA coexist, which has significant clinical relevance. Studies have already shown higher frequencies of pathogenic mtDNA mutations in children with ASD, potentially linked to specific mother-to-child transmission patterns.

Shared Mitochondrial Pathways of ASD Risk Genes

While hundreds of ASD risk genes have been identified, research is increasingly revealing common pathways among them. A significant finding is that a substantial portion of these genes interact with mitochondrial and metabolic pathways. This suggests that a subset of ASD risk genes may directly or indirectly affect mitochondrial function in the brain, opening new avenues for understanding ASD's complex genetic underpinnings.

Mitochondrial Involvement in Neuron Fate Acquisition and Neuronal Development

The timing of neuronal development is critical, and mitochondria appear to play a regulatory role. Research indicates that mitochondrial dynamics, such as fission and fusion, influence cell fate decisions during neurogenesis. Species-specific differences in mitochondrial development and metabolic activity may also contribute to the extended neuronal maturation observed in humans, potentially offering insights into neurodevelopmental conditions like ASD. Furthermore, disruptions in the metabolic shift from immature glycolytic metabolism to mature oxidative metabolism during development, as seen in fragile X syndrome, a known cause of ASD, highlight the importance of mitochondrial timing.

Complexity and Variety in Phenotypes of Mitochondrial Dysfunction

Mitochondrial dysfunction in ASD is not a monolithic issue. The resulting phenotypes are complex and vary significantly across individuals and models. This heterogeneity poses challenges for diagnosis and treatment. Researchers are exploring various sample types, including peripheral markers, to better reflect brain mitochondrial conditions. Additionally, the interplay between environmental exposures, such as flame retardants, and genetic backgrounds can exacerbate mitochondrial dysfunction, impacting brain energy balance during development.

Mitochondrial Effects on Social Behavior

Studies are investigating how mitochondrial deficiencies impact specific experimental systems, including animal and stem cell models, as well as affected individuals. Research on genes like CYFIP1, associated with ASD, has revealed that mutations can lead to compromised brain functional connectivity and ASD-like behaviors. In fruit fly models, CYFIP haploinsufficiency resulted in deficits in social behaviors and brain mitochondrial hyperactivity, mediated by the transporter protein Aralar. Targeting GABA levels or inhibiting mitochondrial hyperactivity showed promise in improving social behavior in these models.

Variation in Mitochondrial DNA Mutations

The same mtDNA mutation can lead to diverse clinical phenotypes depending on the level of energy deficiency. For instance, the tRNALeu(UUR) np m.3243A>G mutation can manifest as ASD, diabetes, or severe childhood disease. Analysis of cells with varying heteroplasmy levels revealed distinct nuclear gene expression patterns that correlate with these phenotypes. Creating a mouse model with a partial mitochondrial defect confirmed that mild mitochondrial dysfunction alone can be sufficient to cause ASD-related traits.

Neuronal Network Changes in Mitochondrial Disorders

In conditions like MELAS, which can co-exist with ASD, a significant proportion of mutated mtDNA is required for symptoms to arise. Studies using human induced pluripotent stem cells (iPSCs) from MELAS patients show that high levels of heteroplasmy lead to mitochondrial dysfunction, affecting neuronal structure, synaptic function, and network activity. These changes could explain neuropsychiatric manifestations. Furthermore, specific neuronal network phenotypes have been linked to syndromes affecting neurodevelopment, including MELAS, suggesting a potential connection to ASD.

Mitochondrial Causes of Neuropsychiatric Symptoms

In 22q11.2 deletion syndrome, where a significant percentage of individuals have ASD or develop schizophrenia, several deleted genes encode proteins localized to mitochondria. Research indicates lower ATP levels in individuals with schizophrenia and this deletion syndrome, suggesting mitochondrial involvement. The question remains whether these mitochondrial changes are a cause or consequence of the psychiatric condition, especially given the influence of sleep, eating, and exercise on metabolic function.

Environment, Mitochondria, and ASD

While many studies focus on mitochondrial deficiencies, some observations in ASD, particularly in children with developmental regression, point to mitochondrial overactivity. This may be a compensatory mechanism for high oxidative stress. Environmental factors, such as prenatal exposure to air pollution or toxic metals, are strongly correlated with mitochondrial dysfunction in childhood, especially in children with ASD and developmental regression, suggesting a role in disrupting neurodevelopment.

Emerging Therapies

Treating primary mitochondrial diseases is challenging due to their complexity. However, the field is progressing with disease-agnostic therapeutic approaches, such as targeting reactive oxygen species, harnessing mitochondrial biogenesis, stabilizing mitochondrial membranes, and targeting mitophagy. Several candidate therapies are in preclinical and early-phase human trials, some of which may be relevant for ASD treatment. Future research will focus on identifying which treatments are most effective for specific patient groups and whether these approaches can be applied to ASD.

Sources

• SFARI workshop explores mitochondrial dysfunction in autism, Simons Foundation Autism Research Initiative | SFARI.